(HHH) Howard Hughes Holdings - Ratings and Ratios
Planned Communities, Retail Properties, Office Buildings, Multifamily Residences, Condominium Developments
Dividends
Currently no dividends paid| Risk via 10d forecast | |
|---|---|
| Volatility | 29.2% |
| Value at Risk 5%th | 43.6% |
| Relative Tail Risk | -9.30% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.13 |
| Alpha | -9.12 |
| CAGR/Max DD | 0.33 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.353 |
| Beta | 0.855 |
| Beta Downside | 0.962 |
| Drawdowns 3y | |
|---|---|
| Max DD | 33.40% |
| Mean DD | 13.42% |
| Median DD | 13.61% |
Description: HHH Howard Hughes Holdings November 07, 2025
Howard Hughes Holdings Inc. (NYSE: HHH) is a U.S. real-estate developer that builds and manages master-planned communities (MPCs) across three operating segments: Operating Assets (retail, office, multifamily and other property acquisitions), MPC (large-scale land development for homebuilders in Las Vegas, Houston and Phoenix), and Strategic Developments (residential condominiums, commercial projects and assorted properties). The firm was founded in 2010 and is headquartered in The Woodlands, Texas.
Key sector drivers for HHH include the continued shortage of affordable housing in Sun Belt metros, which has kept demand for land-banking and multifamily assets high, and the relatively low vacancy rates (≈4.2% nationwide) that support rental growth. Recent quarterly filings show the company’s operating assets generated a cash-flow yield of roughly 6.8%, while its MPC pipeline contains over 12 million sq ft of developable land, a metric that investors track to gauge future revenue visibility.
Given the firm’s exposure to fast-growing markets and its diversified asset mix, a deeper dive into its balance-sheet leverage and land-bank valuation assumptions could clarify upside potential-consider exploring ValueRay’s detailed model for HHH to see how those variables play out under different macro scenarios.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income (274.2m TTM) > 0 and > 6% of Revenue (6% = 110.0m TTM) |
| FCFTA 0.04 (>2.0%) and ΔFCFTA 2.70pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 115.4% (prev 98.90%; Δ 16.48pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.04 (>3.0%) and CFO 439.2m > Net Income 274.2m (YES >=105%, WARN >=100%) |
| Net Debt (3.84b) to EBITDA (802.1m) ratio: 4.78 <= 3.0 (WARN <= 3.5) |
| Current Ratio 4.53 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (59.1m) change vs 12m ago 18.90% (target <= -2.0% for YES) |
| Gross Margin 43.20% (prev 55.31%; Δ -12.11pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 18.22% (prev 11.44%; Δ 6.77pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 3.63 (EBITDA TTM 802.1m / Interest Expense TTM 171.0m) >= 6 (WARN >= 3) |
Altman Z'' 1.68
| (A) 0.20 = (Total Current Assets 2.72b - Total Current Liabilities 599.9m) / Total Assets 10.70b |
| (B) -0.01 = Retained Earnings (Balance) -68.1m / Total Assets 10.70b |
| (C) 0.06 = EBIT TTM 620.9m / Avg Total Assets 10.07b |
| (D) -0.01 = Book Value of Equity -68.9m / Total Liabilities 6.86b |
| Total Rating: 1.68 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 57.31
| 1. Piotroski 4.0pt |
| 2. FCF Yield 4.93% |
| 3. FCF Margin 23.82% |
| 4. Debt/Equity 1.40 |
| 5. Debt/Ebitda 4.78 |
| 6. ROIC - WACC (= 0.75)% |
| 7. RoE 8.45% |
| 8. Rev. Trend -12.37% |
| 9. EPS Trend 1.76% |
What is the price of HHH shares?
Over the past week, the price has changed by +5.78%, over one month by +14.60%, over three months by +20.12% and over the past year by +4.89%.
Is HHH a buy, sell or hold?
- Strong Buy: 0
- Buy: 3
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the HHH price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 97.8 | 8.8% |
| Analysts Target Price | 97.8 | 8.8% |
| ValueRay Target Price | 95.1 | 5.8% |
HHH Fundamental Data Overview November 25, 2025
P/E Trailing = 15.6611
P/E Forward = 33.1126
P/S = 2.739
P/B = 1.3331
P/EG = 5.55
Beta = 1.229
Revenue TTM = 1.83b USD
EBIT TTM = 620.9m USD
EBITDA TTM = 802.1m USD
Long Term Debt = 5.29b USD (from longTermDebt, last quarter)
Short Term Debt = 5.29b USD (from shortTermDebt, last quarter)
Debt = 5.29b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.84b USD (from netDebt column, last quarter)
Enterprise Value = 8.86b USD (5.02b + Debt 5.29b - CCE 1.46b)
Interest Coverage Ratio = 3.63 (Ebit TTM 620.9m / Interest Expense TTM 171.0m)
FCF Yield = 4.93% (FCF TTM 436.8m / Enterprise Value 8.86b)
FCF Margin = 23.82% (FCF TTM 436.8m / Revenue TTM 1.83b)
Net Margin = 14.95% (Net Income TTM 274.2m / Revenue TTM 1.83b)
Gross Margin = 43.20% ((Revenue TTM 1.83b - Cost of Revenue TTM 1.04b) / Revenue TTM)
Gross Margin QoQ = 52.26% (prev 57.12%)
Tobins Q-Ratio = 0.83 (Enterprise Value 8.86b / Total Assets 10.70b)
Interest Expense / Debt = 0.83% (Interest Expense 43.9m / Debt 5.29b)
Taxrate = 24.57% (38.9m / 158.3m)
NOPAT = 468.3m (EBIT 620.9m * (1 - 24.57%))
Current Ratio = 4.53 (Total Current Assets 2.72b / Total Current Liabilities 599.9m)
Debt / Equity = 1.40 (Debt 5.29b / totalStockholderEquity, last quarter 3.77b)
Debt / EBITDA = 4.78 (Net Debt 3.84b / EBITDA 802.1m)
Debt / FCF = 8.78 (Net Debt 3.84b / FCF TTM 436.8m)
Total Stockholder Equity = 3.24b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.56% (Net Income 274.2m / Total Assets 10.70b)
RoE = 8.45% (Net Income TTM 274.2m / Total Stockholder Equity 3.24b)
RoCE = 7.28% (EBIT 620.9m / Capital Employed (Equity 3.24b + L.T.Debt 5.29b))
RoIC = 5.53% (NOPAT 468.3m / Invested Capital 8.47b)
WACC = 4.78% (E(5.02b)/V(10.32b) * Re(9.16%) + D(5.29b)/V(10.32b) * Rd(0.83%) * (1-Tc(0.25)))
Discount Rate = 9.16% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 9.21%
[DCF Debug] Terminal Value 65.57% ; FCFE base≈314.2m ; Y1≈206.3m ; Y5≈94.3m
Fair Price DCF = 26.13 (DCF Value 1.55b / Shares Outstanding 59.4m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 1.76 | EPS CAGR: -0.90% | SUE: 1.14 | # QB: 1
Revenue Correlation: -12.37 | Revenue CAGR: -17.58% | SUE: 0.80 | # QB: 0
EPS next Year (2026-12-31): EPS=4.34 | Chg30d=-0.073 | Revisions Net=+0 | Growth EPS=+64.9% | Growth Revenue=+18.3%
Additional Sources for HHH Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle